Entresto and Anoro ellipta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Entresto (sacubitril; valsartan) and Anoro ellipta (umeclidinium bromide; vilanterol trifenatate). Common drug interactions include lung disorder among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Entresto and Anoro ellipta. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Entresto?

Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,614 Entresto users. Check the latest studies of Entresto.

What is Anoro ellipta?

Anoro ellipta has active ingredients of umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 16,513 Anoro ellipta users. Check the latest studies of Anoro ellipta.



On Nov, 08, 2025

60 people who take Entresto and Anoro ellipta together, and have interactions are studied.

Entresto and Anoro ellipta drug interactions.

What are the common drug interactions of Entresto and Anoro ellipta, by gender? *

Click here to view

What are the common drug interactions of Entresto and Anoro ellipta, by age (0-1 to 60+)? *

Click here to view

What are the existing conditions these people have? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Entresto and Anoro ellipta?

- Personalize this study to your gender, age, symptoms and drugs (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Entresto and Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Common Entresto side effects:

Browse all side effects of Entresto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Anoro ellipta side effects:

Browse all side effects of Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Entresto interactions:

Browse all interactions between Entresto and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Anoro ellipta interactions:

Browse all interactions between Anoro ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sacubitril; valsartan and umeclidinium bromide; vilanterol trifenatate (the active ingredients of Entresto and Anoro ellipta, respectively), and Entresto and Anoro ellipta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: